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ABSTRACT
The PNET of CNS are considered malignant undifferentiated tumors, and it represents about 2,8% 
of all tumors found on infants and teenagers, more rarely found on adults. In the present article will 
report the case of a patient, male, 23 years-old, with nodular lesion inside the third ventricle, admitted 
on emergency room with acute intense headache, drowsiness, vomiting and visual clouding, started 
three days before. Although there have been advances in diagnosis and treatment of PNET in children, 
few publications were found on the efficiency of available treatment options on adults. In our patient 
the lesion was completely removed by a anterosuperior interhemispheric transcallosal craniotomy, and 
subsequently diagnosed as PNET by anatomopathological. Postoperative hydrocephaly was installed 
and reverted with a ventriculoperitoneal shunt, with clinical and neurological status improvement. The 
patient died 18 months after diagnosis, due to respiratory hospitalar infection. 
KEYWORDS
Neuroectodermal tumors, neuroectodermal tumors primitive, medulloblastoma, cerebral ventricle 
neoplasms, third ventricle.
RESUMO
Tumor neuroectodérmico primário (PNET) supratentorial no terceiro ventrículo em adulto: um 
raro relato de caso
Os PNET do SNC são considerados tumores malignos indiferenciados e representam cerca de 2,8% 
de todos os tumores encontrados em crianças e adolescentes, sendo mais raramente encontrados em 
adultos. Neste presente artigo, relatamos o caso de um paciente, do sexo masculino, com 23 anos de 
idade, com lesão nodular dentro do terceiro ventrículo, que foi admitido na emergência com cefaleia 
intensa e aguda, sonolência, vômitos e turvação visual, iniciados três dias antes da admissão. Embora 
tenha havido avanços no diagnóstico e tratamento de PNET em crianças, poucas publicações foram 
encontradas sobre a eficiência de opções de tratamento disponíveis em adultos. No nosso paciente 
a lesão foi completamente removida por uma craniotomia ântero-transcalosa inter-hemisférica; 
posteriormente, ele foi diagnosticado como PNET por meio do exame anatomopatológico. A hidrocefalia 
instalada no pós-operatório foi revertida com uma derivação ventrículo-peritoneal, com melhora do 
quadro clínico e neurológico. O paciente morreu 18 meses após o diagnóstico, em decorrência de 
uma infecção hospitalar respiratória.
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Introduction
The primary neuroectodermal tumors (PNET) of 
central nervous system (CNS) are genetically classified 
on a subset of heterogenic embrionary tumors with di-
vergent differentiation, and an aggressive behavior like 
cerebellar medulloblastoma and other medulloblasto-
ma-like tumors located on other sites.1,2 They are found 
mainly in children and adolescents, and more rarely 
found in adults, and when they occur, are predominant 
in the brain parenchyma or in the suprasellar region.3 
We report an adult patient with a supratentorial PNET, 
located inside the third ventricle, describing its clinical 
course, and discussing the anatomic presentation and 
the immunopathology of this rare case.
Case report
Patient, male, 23 years-old (YO), admitted on emer-
gency room with acute intense headache, drowsiness, 
with vomiting and visual clouding, started three days 
ago. No history of fever or seizures. Patient had not fam-
ily history of brain tumors or known genetic syndromes. 
Neurological examination showed a patient in Glasgow 
Coma Scale: 14, drowsy, cranial nerves normal, without 
motor or sensitive deficit, and deep tendon reflexes 
was normal. In ocular fundus exam had not signs of 
papilledema.
The computer tomography (CT) showed a nodular 
lesion (2,1 x 2,0 cm), inside the 3rd ventricle, with small 
enhancement after iodinated contrast, interrupting li-
quoric flow, causing non-communicant hydrocephaly. 
In the same day was performed a ventriculoscopy to 
approach the lesion, causing bleeding during the 
procedure, hindering complete tumor removal. After 
hemostasis (Figure 1), an external ventricular drainage 
was inserted, and in a second time it was performed an 
anterosuperior interhemispheric transcallosal crani-
otomy, removing the hole lesion (Figure 2). Permanent 
postoperative hydrocephaly was installed and reverted 
with a ventriculoperitoneal shunt, with clinical and 
neurological status improvement (Figure 3). 
The CSF analysis obtained during surgical procedure 
did not detect neoplasic cells. The patient was set free 
for clinical oncologic following. During oncogic follow 
and before beginning the complementary adjuvant 
treatment, it has been installed a subacute paraparesis, 
grade 3/5 in left lower extremity, grade 4/5 in right 
lower extremity, with a sensibility loss level at T2 and 
neurogenic bladder dysfunction, secondary to upper 
thoracic myelopathy. It was performed a whole vertebral 
spine Magnetic Resonance Imaging (Figure 4), that 
showed multiple lesions on cervical, dorsal and lumbar 
extramedullary epidural space. It has been performed a 
decompressive laminectomy, from T4 to T6, with tho-
racic medullary lesion removal. The anatomopathology 
result was PNET. Gallium bone scan does not show any 
abnormalities, as thoracic CT scan as well. Twelve weeks 
after that (1 year and 6 months after first symptom), the 
patient died, due to respiratory hospitalar infection.
Figure 1 – Head CT without contrast, realized after 
neuroendoscopy, showing an intraventricular (3rd ventricle) 
heterogenic nodular lesion, with evidence of intraventricular 
hemorrhage and frontal pneumocephalus.
Figure 2 – Head MRI on postoperative, T1 with contrast (A) and T2 
(B), showing no evidence of macroscopic intraventricular lesion.
Figure 3 – Control head CT without contrast after 
ventriculoperitoneal shunt.
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Pathology findings
The result of the anatomopathology was a high-grade 
malignant neoplasm, characterized by rounded or oval-
shaped atypical cells, with evident stained nucleus and 
conspicuous nucleolus. Atypical mitosis and apoptotic 
bodies were easily seen. Also, there were areas where 
tumor cells had been presented more united, with clear 
and ample cytoplasm (Figure 5). Immunohistochemical 
study revealed chromogranin A, sinaptophysin, CD99 
and sparse S-100 presence (Table 1). These findings 
are consistent with PNET grade IV, according to the 
classification of the World Health Organization. By 
the histopathological study of medullary lesion, it has 
been found an immature neoplasia, characterized by 
typical PNET presentation as in the 3rd ventricle tumor 
(rounded and oval-shaped cells, high-stained, with 
atypical mitosis, on an infiltrative pattern). 
Discussion
The PNET are considered malignant embryonic 
tumors, with cerebellar medulloblastoma as its most 
frequent form, about 80%, occurring mostly younger 
than 15 years old. Medulloblastomas may also occur 
at other sites, in addition to the cerebellum, without to 
have histological differences, but with clinical outcome 
Figure 4 – Sagital neuroaxial T2 MRI, showing multiple lesions in extramedullary intradural space; cervical (A), thoracic (B) and lumbar (C).
Figure 5 – PNET microscopic images.
Table 1 – PNET immunohistochemical results
Antibodies Clone Result
Antigen of cellular proliferation Ki-67 MIB1 Positive 40%
CD99 – Protein MIC-2 (p30/32) O13 Positive  Focally
Cytokeratin of 40, 48, 50 and 50,6 kDa AE1/AE3 Negative
Chromogranin A DAK-A3 Positive
Protein S-100 Policlonal Positive  Focal
Synaptophysin SP11 Positive
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and response to therapy differently. It is know that su-
pratentorial PNET have a worse prognosis compared to 
infratentorial location.4 In adults the PNET represent 
only 1% of adult tumors and when they occur the pre-
dominant subtype is the desmoplastic.5 Balafouta et 
al.,1 after literature revision, reported in adults only 21 
supratentorial PNET cases (29 YO average, ranging 19-
57 years/male = female), with high prevalence to tempo-
roparietal area. Only one case the tumor was located on 
3rd ventricle, seemed with our case, presenting also in a 
23rd years-old male patient. In a wide search result from 
PubMed, in the last ten years just four intraventricular 
PNET cases on adults were reported.6,7 
The capacity of differentiation into various neural 
cell lineages and the anatomical proximity of the supra-
sellar region and the third ventricle with the sharing of 
oncogenic potential cells could explain that localization, 
theory shared by the authors, although by definition 
the supratentorial PNET are located in the cerebral 
hemispheres or suprasellar region. 
PNET may have cystic formations, but they are 
commonly solid masses, with variable consistency, and 
necrosis areas and vascular proliferation. Calcifications 
and hemorrhages are rare.8 Histologically they show a 
basic cells pattern, undifferentiated, capable to differ-
entiate on glial, neuronal, myogenic and melanocytic 
lineages and a neuronal arrange with Homer-Wright 
rosettes-like (neuroblastic rosettes with tumoral nuclei 
in a circular disposition around typical, but not pathog-
nomonic, cytoplasmic processes, and with high mitosis 
activity and cellular pleomorphism).4,8,9
Some clinical conditions are strong association with 
PNET: Gorlin’s syndrome (combined neoplasias and 
malformations including basal cell nevoid carcinoma, 
odontogenic cysts in the jaw, skeletal abnormalities, 
ovarian fibroma and early medulloblastomas), Turcot’s 
syndrome (autossomic dominant disorder with colorec-
tal neoplasias, medulloblastomas or glioblastomas) 
and Li-Fraumeni’s syndrome (autossomic dominant 
disorder characterized by multiple tumors on infants 
including sarcomas, breast cancer, leukemia and brain 
tumors) are more associated, generally occurring on 
infants; normally they have abnormal cariotypes.8  
On immunohistochemistry, PNET are positive for 
GFAP (glial fibrillary acid protein), neuron specific 
enolase, synaptophysin and CD-99. In our patient, we 
found also positivity chromogranin and S-100. The 
ultra-structural analysis showed only neurosecretory 
granules, there was no microtubular or intermediate 
filaments structures.9 The MIB1 index is usually high, 
showing the high cellularity and differentiation of 
these kind of tumors. Chromosome 17 short-arm lose 
(17p13.3) is the most common genetic mutation, and 
this finding is directly related with worse prognostic, 
mainly on medulloblastomas. Another genetic loci 
possibly related to medulloblastoma pathogenesis 
includes PAX and SSH (sonic hedgehog gene) genes, 
under investigation.8 but these alterations or mutations 
of components of the sonic hedgeog pathway are uncom-
mon in supratentorial PNET.4
It is already known that rachimedular metastasis is 
the most common dissemination form these tumors,8 
also found in the described patient, justifying the 
screening done for these kind of lesion. Primary intra-
spinal PNET are rare and when occurs, it also leads to 
a worse prognostic. 
The treatment for adults should not significantly 
differ from the one for children. However according to 
the study of Sarkar et al.10 the survival benefit in adults 
does not seem related with the histological variant 
(classical versus desmoplastic variant) but rather with 
the age. Although the total resection improve survival 
and be the first step on PNET handling, staging must 
include neurospinal MRI and CSF analysis, looking for 
posterior radiotherapy and adjuvant chemotherapy.11 
In despite of standard screening, recommended just 
in symptomatic patients, and the fact of extraspinal 
metastasis be uncommon, our patient was submitted 
to a bone scan with scintigraphy and thorax TC scan, 
no pathologic findings. 
Although radiotherapy seems to improve survival 
on these patients, the evolution in general is poor, and 
the majority of patients develop multiple metastasis on 
CNS, or loco-regional recurrences. And the adjuvant 
chemotherapy with agents like Vincristine, CCNU and 
Cisplatin may have benefits comparing to radiotherapy, 
once that PNET seem to be more radioresistents than 
medulloblastomas, indicating greater survival rates.1 
The main survival on adults is around 22 months, 
and it seems to be equivalent on children. In this case 
report, the patient died 18 months after diagnosis, a little 
less than the average found on literature. 
Although there has been advanced on diagnosis 
and treatment of PNET in this decade in children, 
mainly after the huge advance of image techniques and 
adjuvant treatments, we can find just a few publica-
tions approaching the efficiency of available treatment 
options on adults. Our case report, as the others we 
found, might be an important substratum to posterior 
important studied. 
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